Heterogeneous response of different tumor cell lines to methotrexate-coupled nanoparticles in presence of hyperthermia

Marcus Stapf,* Nadine Pömpner,* Ulf Teichgräber, Ingrid HilgerInstitute of Diagnostic and Interventional Radiology, Department of Experimental Radiology, Jena University Hospital, Friedrich-Schiller University, Jena, Germany*These authors contributed equally to this workAb...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Stapf M, Pömpner N, Teichgräber U, Hilger I
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/d679c4e0eb4b4cf98cf903772c728c71
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d679c4e0eb4b4cf98cf903772c728c71
record_format dspace
spelling oai:doaj.org-article:d679c4e0eb4b4cf98cf903772c728c712021-12-02T03:58:36ZHeterogeneous response of different tumor cell lines to methotrexate-coupled nanoparticles in presence of hyperthermia1178-2013https://doaj.org/article/d679c4e0eb4b4cf98cf903772c728c712016-02-01T00:00:00Zhttps://www.dovepress.com/heterogeneous-response-of-different-tumor-cell-lines-to-methotrexate-c-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Marcus Stapf,* Nadine Pömpner,* Ulf Teichgräber, Ingrid HilgerInstitute of Diagnostic and Interventional Radiology, Department of Experimental Radiology, Jena University Hospital, Friedrich-Schiller University, Jena, Germany*These authors contributed equally to this workAbstract: Today, the therapeutic efficacy of cancer is restricted by the heterogeneity of the response of tumor cells to chemotherapeutic drugs. Since those therapies are also associated with severe side effects in nontarget organs, the application of drugs in combination with nanocarriers for targeted therapy has been suggested. Here, we sought to assess whether the coupling of methotrexate (MTX) to magnetic nanoparticles (MNP) could serve as a valuable tool to circumvent the heterogeneity of tumor cell response to MTX by the combined treatment with hyperthermia. To this end, we investigated five breast cancer cell lines of different origin and with different mutational statuses, as well as a bladder cancer cell line in terms of their response to exposure to MTX as a free drug or after its coupling to MNP as well as in presence/absence of hyperthermia. We also assessed whether the effects could be connected to the cell line-specific expression of proteins related to the uptake and efflux of MTX and MNP. Our results revealed a very heterogeneous and cell line-dependent response to an exposure with MTX-coupled MNP (MTX–MNP), which was almost comparable to the efficacy of free MTX in the same cell line. Moreover, a cell line-specific and preferential uptake of MTX–MNP compared with MNP alone was found (probably by receptor-mediated endocytosis), agreeing with the observed cytotoxic effects. Opposed to this, the expression pattern of several cell membrane transport proteins noted for MTX uptake and efflux was only by tendency in agreement with the cellular toxicity of MTX–MNP in different cell lines. Higher cytotoxic effects were achieved by exposing cells to a combination of MTX–MNP and hyperthermal treatment, compared with MTX or thermotherapy alone. However, the heterogeneity in the response of the tumor cell lines to MTX could not be completely abolished – even after its combination with MNP and/or hyperthermia – and the application of higher thermal dosages might be necessary.Keywords: magnetic nanoparticles, SPION, in vitro, methotrexate, hyperthermia, breast cancer, bladder cancerStapf MPömpner NTeichgräber UHilger IDove Medical Pressarticlemagnetic nanoparticles (MNP)SPIONin vitromethotrexate (MTX)hyperthermiabreast cancerbladder cancerMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2016, Iss Issue 1, Pp 485-500 (2016)
institution DOAJ
collection DOAJ
language EN
topic magnetic nanoparticles (MNP)
SPION
in vitro
methotrexate (MTX)
hyperthermia
breast cancer
bladder cancer
Medicine (General)
R5-920
spellingShingle magnetic nanoparticles (MNP)
SPION
in vitro
methotrexate (MTX)
hyperthermia
breast cancer
bladder cancer
Medicine (General)
R5-920
Stapf M
Pömpner N
Teichgräber U
Hilger I
Heterogeneous response of different tumor cell lines to methotrexate-coupled nanoparticles in presence of hyperthermia
description Marcus Stapf,* Nadine Pömpner,* Ulf Teichgräber, Ingrid HilgerInstitute of Diagnostic and Interventional Radiology, Department of Experimental Radiology, Jena University Hospital, Friedrich-Schiller University, Jena, Germany*These authors contributed equally to this workAbstract: Today, the therapeutic efficacy of cancer is restricted by the heterogeneity of the response of tumor cells to chemotherapeutic drugs. Since those therapies are also associated with severe side effects in nontarget organs, the application of drugs in combination with nanocarriers for targeted therapy has been suggested. Here, we sought to assess whether the coupling of methotrexate (MTX) to magnetic nanoparticles (MNP) could serve as a valuable tool to circumvent the heterogeneity of tumor cell response to MTX by the combined treatment with hyperthermia. To this end, we investigated five breast cancer cell lines of different origin and with different mutational statuses, as well as a bladder cancer cell line in terms of their response to exposure to MTX as a free drug or after its coupling to MNP as well as in presence/absence of hyperthermia. We also assessed whether the effects could be connected to the cell line-specific expression of proteins related to the uptake and efflux of MTX and MNP. Our results revealed a very heterogeneous and cell line-dependent response to an exposure with MTX-coupled MNP (MTX–MNP), which was almost comparable to the efficacy of free MTX in the same cell line. Moreover, a cell line-specific and preferential uptake of MTX–MNP compared with MNP alone was found (probably by receptor-mediated endocytosis), agreeing with the observed cytotoxic effects. Opposed to this, the expression pattern of several cell membrane transport proteins noted for MTX uptake and efflux was only by tendency in agreement with the cellular toxicity of MTX–MNP in different cell lines. Higher cytotoxic effects were achieved by exposing cells to a combination of MTX–MNP and hyperthermal treatment, compared with MTX or thermotherapy alone. However, the heterogeneity in the response of the tumor cell lines to MTX could not be completely abolished – even after its combination with MNP and/or hyperthermia – and the application of higher thermal dosages might be necessary.Keywords: magnetic nanoparticles, SPION, in vitro, methotrexate, hyperthermia, breast cancer, bladder cancer
format article
author Stapf M
Pömpner N
Teichgräber U
Hilger I
author_facet Stapf M
Pömpner N
Teichgräber U
Hilger I
author_sort Stapf M
title Heterogeneous response of different tumor cell lines to methotrexate-coupled nanoparticles in presence of hyperthermia
title_short Heterogeneous response of different tumor cell lines to methotrexate-coupled nanoparticles in presence of hyperthermia
title_full Heterogeneous response of different tumor cell lines to methotrexate-coupled nanoparticles in presence of hyperthermia
title_fullStr Heterogeneous response of different tumor cell lines to methotrexate-coupled nanoparticles in presence of hyperthermia
title_full_unstemmed Heterogeneous response of different tumor cell lines to methotrexate-coupled nanoparticles in presence of hyperthermia
title_sort heterogeneous response of different tumor cell lines to methotrexate-coupled nanoparticles in presence of hyperthermia
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/d679c4e0eb4b4cf98cf903772c728c71
work_keys_str_mv AT stapfm heterogeneousresponseofdifferenttumorcelllinestomethotrexatecouplednanoparticlesinpresenceofhyperthermia
AT pompnern heterogeneousresponseofdifferenttumorcelllinestomethotrexatecouplednanoparticlesinpresenceofhyperthermia
AT teichgraberu heterogeneousresponseofdifferenttumorcelllinestomethotrexatecouplednanoparticlesinpresenceofhyperthermia
AT hilgeri heterogeneousresponseofdifferenttumorcelllinestomethotrexatecouplednanoparticlesinpresenceofhyperthermia
_version_ 1718401522267586560